![CD28 : B7-1 [Biotinylated] Inhibitor Screening ELISA Kit](/_ipx/q_100,fit_outside,s_360x255/images/no-image-product-box.jpg "CD28 : B7-1 [Biotinylated] Inhibitor Screening ELISA Kit")
![CD28 : B7-1 [Biotinylated] Inhibitor Screening ELISA Kit](/_ipx/_/images/no-image-product-box.jpg "CD28 : B7-1 [Biotinylated] Inhibitor Screening ELISA Kit")
CD28 : B7-1 [Biotinylated] Inhibitor Screening ELISA Kit
1246.66 €
In Stock
quantity
product details
Catalog number: 716 - EP-150-96tests
Product Category: Business & Industrial > Science & Laboratory
Gentaur
Size: 96tests
![CD28 : B7-1 [Biotinylated] Inhibitor Screening ELISA Kit](/images/no-image-product-box.jpg "CD28 : B7-1 [Biotinylated] Inhibitor Screening ELISA Kit")
EP-150
CD28 : B7-1 [Biotinylated] Inhibitor Screening ELISA Kit
T-cell-specific surface glycoprotein CD28 is also known as TP44, is a single-pass type I membrane protein which contains one Ig-like V-type (immunoglobulin-like) domain. is one of the molecules expressed on T cells that provide co-stimulatory signals, which are required for T cell activation. CD28 is the receptor for B7-1 (CD80) and B7-2 (CD86). When activated by Toll-like receptor ligands, the CD80 expression is upregulated in antigen presenting cells (APCs). The CD86 expression on antigen presenting cells is constitutive. CD28 is the only B7 receptor constitutively expressed on naive T cells.
1246.66 €
EP-150-96tests
CD28 : B7-1 [Biotinylated] Inhibitor Screening ELISA Kit
T-cell-specific surface glycoprotein CD28 is also known as TP44, is a single-pass type I membrane protein which contains one Ig-like V-type (immunoglobulin-like) domain. is one of the molecules expressed on T cells that provide co-stimulatory signals, which are required for T cell activation. CD28 is the receptor for B7-1 (CD80) and B7-2 (CD86). When activated by Toll-like receptor ligands, the CD80 expression is upregulated in antigen presenting cells (APCs). The CD86 expression on antigen presenting cells is constitutive. CD28 is the only B7 receptor constitutively expressed on naive T cells.
1246.66 €
EP-116
B7-1 [Biotinylated] : CTLA-4 Inhibitor Screening ELISA Kit
Cytotoxic T lymphocyte associated ANTIgen-4 (CTLA-4), also known as CD152, is a kind of leukocyte differentiation antigen and a transmembrane receptor on T cells, sharing B7 ligand with CD28. The binding of CTLA-4 with B7 induces T cells to be non-reactive and participates in the negative regulation of immune response. The recombinant CTLA-4 Ig can effectively and specifically inhibit cellular and humoral immune responses in vivo and in vitro, and has significant therapeutic effects on transplant rejection and various autoimmune diseases with very low toxicity. It is considered as a promising new immunosuppressive drug at present.
1074.92 €
EP-120
PD-1 [Biotinylated] : PD-L2 Inhibitor Screening ELISA Kit
PD-L2, also known as CD273 or B7-DC, is a member of the B7 family protein with PD-L1, and it is the second important ligand that can bind pD-1 after PD-L1. The human PD-L2(B7-H2, CD273) gene is also located on chromosome 9p24, encoding type I transmembrane protein with 247 amino acids. The homology of PD-L1 and PD-L2 was 40%. The affinity between PD-L2 and PD-1 is 2-6 times that of PD-L1. Compared with PD-L1, the expression of PD-L2 is relatively limited, and pD-L2 is induced to express on the surface of dendritic cells, macrophages, bone marrow derived mast cells and other cells.
1074.92 €
EP-120-96tests
PD-1 [Biotinylated] : PD-L2 Inhibitor Screening ELISA Kit
PD-L2, also known as CD273 or B7-DC, is a member of the B7 family protein with PD-L1, and it is the second important ligand that can bind pD-1 after PD-L1. The human PD-L2(B7-H2, CD273) gene is also located on chromosome 9p24, encoding type I transmembrane protein with 247 amino acids. The homology of PD-L1 and PD-L2 was 40%. The affinity between PD-L2 and PD-1 is 2-6 times that of PD-L1. Compared with PD-L1, the expression of PD-L2 is relatively limited, and pD-L2 is induced to express on the surface of dendritic cells, macrophages, bone marrow derived mast cells and other cells.
1074.92 €
EP-130
PD-1 : PD-L1 [Biotinylated] Inhibitor Screening ELISA Kit
Immune checkpoint pathway is a focal point of today’s cancer research. PD-1 is one of the best characterized checkpoint proteins. The binding between PD-1 and its ligand PD-L1 suppresses T-cell activation and allows cancer cells to escape from body’s immune surveillance. Therefore, the pharmaceutical inhibition of PD-1 or its ligand has been considered a promising strategy by many oncologists.